Clusterin silencing restores myoblasts viability and down modulates the inflammatory process in osteoporotic disease
Abstract Background Targeting new molecular pathways leading to Osteoporosis (OP) and Osteoarthritis (OA) is a hot topic for drug discovery. Clusterin (CLU) is a glycoprotein involved in inflammation, proliferation, cell death, neoplastic disease, Alzheimer disease and aging. The present study focus...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-04-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12967-019-1868-5 |
id |
doaj-8e178d5ae45649558fe27d2522c9e47f |
---|---|
record_format |
Article |
spelling |
doaj-8e178d5ae45649558fe27d2522c9e47f2020-11-25T02:03:06ZengBMCJournal of Translational Medicine1479-58762019-04-0117111610.1186/s12967-019-1868-5Clusterin silencing restores myoblasts viability and down modulates the inflammatory process in osteoporotic diseaseS. Pucci0C. Greggi1C. Polidoro2M. C. Piro3M. Celi4M. Feola5E. Gasbarra6R. Iundusi7F. Mastrangeli8G. Novelli9A. Orlandi10U. Tarantino11Department of Biomedicine and Prevention, Tor Vergata University of RomeDepartment of Clinical Sciences and Translational Medicine, University of Rome Tor VergataDepartment of Biomedicine and Prevention, Tor Vergata University of RomeDepartment of Experimental Medicine and Surgery, University of Rome “Tor Vergata”Department of Clinical Sciences and Translational Medicine, University of Rome Tor VergataDepartment of Clinical Sciences and Translational Medicine, University of Rome Tor VergataDepartment of Clinical Sciences and Translational Medicine, University of Rome Tor VergataDepartment of Clinical Sciences and Translational Medicine, University of Rome Tor VergataDepartment of Clinical Sciences and Translational Medicine, University of Rome Tor VergataDepartment of Biomedicine and Prevention, Tor Vergata University of RomeDepartment of Biomedicine and Prevention, Tor Vergata University of RomeDepartment of Clinical Sciences and Translational Medicine, University of Rome Tor VergataAbstract Background Targeting new molecular pathways leading to Osteoporosis (OP) and Osteoarthritis (OA) is a hot topic for drug discovery. Clusterin (CLU) is a glycoprotein involved in inflammation, proliferation, cell death, neoplastic disease, Alzheimer disease and aging. The present study focuses on the expression and the role of CLU in influencing the decrease of muscle mass and fiber senescence in OP-OA condition. Methods Vastus lateralis muscle biopsies were collected from 20 women with OP undergoing surgery for fragility hip fracture and 20 women undergoing arthroplasty for hip osteoarthritis. Results We found an overexpression of CLU in degenerated fibers in OP closely correlated with interleukin 6 (IL6) and histone H4 acetylation level. Conversely, in OA muscle tissues we observed a weak expression of CLU but no nuclear histone H4 acetylation. Ex vivo studies on isolated human myoblasts confirmed CLU overexpression in OP as compared to OA (p < 0.001). CLU treatment of isolated OP and OA myoblasts showed: modulation of proliferation, morphological changes, increase of histone H4 acetylation and induction of myogenin (MYOG) activation in OP myoblast only. In OP condition, functional knockdown of CLU by siRNA restores proliferative myoblasts capability and tissue damage repair, carried out by an evident upregulation of Transglutaminase 2 (TGM2). We also observed downmodulation of CX3CR1 expression with consequent impairing of the inflammatory infiltrate recruitment. Conclusions Results obtained suggest a potential role of CLU in OP by influencing myoblasts terminal differentiation, epigenetic regulation of muscle cell differentiation and senescence. Moreover, CLU silencing points out its role in the modulation of tissue damage repair and inflammation, proposing it as a new diagnostic marker for muscle degeneration and a potential target for specific therapeutic intervention in OP related sarcopenia.http://link.springer.com/article/10.1186/s12967-019-1868-5Clusterin (CLU)OsteoporosisOsteoarthritisSarcopeniaMuscle waistOsteoporosis marker |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
S. Pucci C. Greggi C. Polidoro M. C. Piro M. Celi M. Feola E. Gasbarra R. Iundusi F. Mastrangeli G. Novelli A. Orlandi U. Tarantino |
spellingShingle |
S. Pucci C. Greggi C. Polidoro M. C. Piro M. Celi M. Feola E. Gasbarra R. Iundusi F. Mastrangeli G. Novelli A. Orlandi U. Tarantino Clusterin silencing restores myoblasts viability and down modulates the inflammatory process in osteoporotic disease Journal of Translational Medicine Clusterin (CLU) Osteoporosis Osteoarthritis Sarcopenia Muscle waist Osteoporosis marker |
author_facet |
S. Pucci C. Greggi C. Polidoro M. C. Piro M. Celi M. Feola E. Gasbarra R. Iundusi F. Mastrangeli G. Novelli A. Orlandi U. Tarantino |
author_sort |
S. Pucci |
title |
Clusterin silencing restores myoblasts viability and down modulates the inflammatory process in osteoporotic disease |
title_short |
Clusterin silencing restores myoblasts viability and down modulates the inflammatory process in osteoporotic disease |
title_full |
Clusterin silencing restores myoblasts viability and down modulates the inflammatory process in osteoporotic disease |
title_fullStr |
Clusterin silencing restores myoblasts viability and down modulates the inflammatory process in osteoporotic disease |
title_full_unstemmed |
Clusterin silencing restores myoblasts viability and down modulates the inflammatory process in osteoporotic disease |
title_sort |
clusterin silencing restores myoblasts viability and down modulates the inflammatory process in osteoporotic disease |
publisher |
BMC |
series |
Journal of Translational Medicine |
issn |
1479-5876 |
publishDate |
2019-04-01 |
description |
Abstract Background Targeting new molecular pathways leading to Osteoporosis (OP) and Osteoarthritis (OA) is a hot topic for drug discovery. Clusterin (CLU) is a glycoprotein involved in inflammation, proliferation, cell death, neoplastic disease, Alzheimer disease and aging. The present study focuses on the expression and the role of CLU in influencing the decrease of muscle mass and fiber senescence in OP-OA condition. Methods Vastus lateralis muscle biopsies were collected from 20 women with OP undergoing surgery for fragility hip fracture and 20 women undergoing arthroplasty for hip osteoarthritis. Results We found an overexpression of CLU in degenerated fibers in OP closely correlated with interleukin 6 (IL6) and histone H4 acetylation level. Conversely, in OA muscle tissues we observed a weak expression of CLU but no nuclear histone H4 acetylation. Ex vivo studies on isolated human myoblasts confirmed CLU overexpression in OP as compared to OA (p < 0.001). CLU treatment of isolated OP and OA myoblasts showed: modulation of proliferation, morphological changes, increase of histone H4 acetylation and induction of myogenin (MYOG) activation in OP myoblast only. In OP condition, functional knockdown of CLU by siRNA restores proliferative myoblasts capability and tissue damage repair, carried out by an evident upregulation of Transglutaminase 2 (TGM2). We also observed downmodulation of CX3CR1 expression with consequent impairing of the inflammatory infiltrate recruitment. Conclusions Results obtained suggest a potential role of CLU in OP by influencing myoblasts terminal differentiation, epigenetic regulation of muscle cell differentiation and senescence. Moreover, CLU silencing points out its role in the modulation of tissue damage repair and inflammation, proposing it as a new diagnostic marker for muscle degeneration and a potential target for specific therapeutic intervention in OP related sarcopenia. |
topic |
Clusterin (CLU) Osteoporosis Osteoarthritis Sarcopenia Muscle waist Osteoporosis marker |
url |
http://link.springer.com/article/10.1186/s12967-019-1868-5 |
work_keys_str_mv |
AT spucci clusterinsilencingrestoresmyoblastsviabilityanddownmodulatestheinflammatoryprocessinosteoporoticdisease AT cgreggi clusterinsilencingrestoresmyoblastsviabilityanddownmodulatestheinflammatoryprocessinosteoporoticdisease AT cpolidoro clusterinsilencingrestoresmyoblastsviabilityanddownmodulatestheinflammatoryprocessinosteoporoticdisease AT mcpiro clusterinsilencingrestoresmyoblastsviabilityanddownmodulatestheinflammatoryprocessinosteoporoticdisease AT mceli clusterinsilencingrestoresmyoblastsviabilityanddownmodulatestheinflammatoryprocessinosteoporoticdisease AT mfeola clusterinsilencingrestoresmyoblastsviabilityanddownmodulatestheinflammatoryprocessinosteoporoticdisease AT egasbarra clusterinsilencingrestoresmyoblastsviabilityanddownmodulatestheinflammatoryprocessinosteoporoticdisease AT riundusi clusterinsilencingrestoresmyoblastsviabilityanddownmodulatestheinflammatoryprocessinosteoporoticdisease AT fmastrangeli clusterinsilencingrestoresmyoblastsviabilityanddownmodulatestheinflammatoryprocessinosteoporoticdisease AT gnovelli clusterinsilencingrestoresmyoblastsviabilityanddownmodulatestheinflammatoryprocessinosteoporoticdisease AT aorlandi clusterinsilencingrestoresmyoblastsviabilityanddownmodulatestheinflammatoryprocessinosteoporoticdisease AT utarantino clusterinsilencingrestoresmyoblastsviabilityanddownmodulatestheinflammatoryprocessinosteoporoticdisease |
_version_ |
1724949532666494976 |